title: Perioperative administration of single, high-dose of ATG-Fresenius-S as an induction immunosuppressive therapy in cadaveric renal transplantation: preliminary results.
authors.affiliation: Transplantation Institute, The Medical University of Warsaw and the County Hospital, Poznań, Poland.
authors.forename: R
authors.initials: R
authors.lastname: Samsel
authors.forename: W
authors.initials: W
authors.lastname: Rowiński
authors.forename: A
authors.initials: A
authors.lastname: Chmura
authors.forename: Z
authors.initials: Z
authors.lastname: Włodarczyk
authors.forename: J
authors.initials: J
authors.lastname: Wyzgał
authors.forename: T
authors.initials: T
authors.lastname: Cieciura
authors.forename: B
authors.initials: B
authors.lastname: Łagiewska
authors.forename: J
authors.initials: J
authors.lastname: Pliszczyński
authors.forename: G
authors.initials: G
authors.lastname: Korczak
authors.forename: L
authors.initials: L
authors.lastname: Paczek
authors.forename: J
authors.initials: J
authors.lastname: Wałaszewski
authors.forename: M
authors.initials: M
authors.lastname: Lao
mesh_terms: D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D002102:Cadaver; D005260:Female; D005500:Follow-Up Studies; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D008875:Middle Aged; D012449:Safety; D013997:Time Factors; D014019:Tissue Donors
chemical_list: D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents